Lista de obras - Antonio Coppola - Dominio Público Uruguay

A role for von Willebrand factor in immune tolerance induction in patients with haemophilia A and inhibitors?

artículo científico publicado en 2011

Aberrant F8 gene intron 1 inversion with concomitant duplication and deletion in a severe hemophilia A patient from Southern Italy.

artículo científico publicado en 2013

Acquired haemophilia a in the elderly: case reports.

artículo científico publicado en 2010

Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management

artículo científico publicado en 2015

Acute coronary syndrome and severe haemophilia: an unusual association with challenging treatment

artículo científico publicado en 2010

Air pollution, vascular disease and thrombosis: linking clinical data and pathogenic mechanisms.

artículo científico publicado en 2012

Antiphospholipid syndrome, adrenal failure, dilated cardiomyopathy and chronic hepatitis: an unusual manifestation of multiorgan autoimmune injury?

artículo científico publicado en 1998

Assessing joint involvement in haemophilia by clinical rheumatologic scores. A pilot study on similarities with subjects with psoriatic arthritis

artículo científico publicado en 2011

Assessment of Hemophilic Arthropathy by Ultrasound: Where Do We Stand?

artículo científico publicado en 2016

Atherothrombosis in von Willebrand Disease: An Analysis of the Literature and Implications for Clinical Management ⬇️

artículo científico publicado el 5 de marzo de 2012

Bleeding and Thrombosis in Multiple Myeloma and Related Plasma Cell Disorders ⬇️

artículo científico publicado el 23 de diciembre de 2011

Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers

artículo científico publicado en 2012

Cardiovascular risk factors and outcome in patients with retinal vein occlusion

artículo científico publicado en 2010

Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis

artículo científico publicado en 2012

Clinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentrates

artículo científico publicado en 2013

Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients

artículo científico publicado en 2007

Confronting the psychological burden of haemophilia.

artículo científico publicado en 2011

Controversies in Inherited Bleeding Disorders

artículo científico publicado en 2016

Coronary artery disease, cerebral non-fatal ischemic stroke in retinal vein occlusion: an 8-yr follow-up

artículo científico publicado en 2010

Corrigendum

scholarly article published in British Journal of Haematology

Cost of care of haemophilia with inhibitors.

artículo científico publicado en 2009

Current and evolving features in the clinical management of haemophilia

artículo científico publicado en 2014

Current management of the hemophilic child: a demanding interlocutor. Quality of life and adequate cost-efficacy analysis

artículo científico publicado en 2014

Definition of an organisational model for the prevention and reduction of health and social impacts of inherited bleeding disorders.

artículo científico publicado en 2014

Denaturing HPLC procedure for factor IX gene scanning.

artículo científico publicado en 2003

Diabetes, vascular complications and antiplatelet therapy: open problems.

scientific article published on 02 December 2008

Effects of secondary prophylaxis started in adolescent and adult haemophiliacs

artículo científico publicado en 2008

Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease.

artículo científico publicado en 2012

Emerging issues on comprehensive hemophilia care: preventing, identifying, and monitoring age-related comorbidities

artículo científico publicado en 2013

FEIBA versus NovoSeven in hemophilia patients with inhibitors

artículo científico

Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors.

artículo científico publicado en 2009

Factors influencing illness representations and perceived adherence in haemophilic patients: a pilot study

artículo científico publicado en 2015

First Diagnosis of Hemophilia B in a Nonagenarian.

artículo científico publicado en 2016

Forum on: the role of recombinant factor VIII in children with severe haemophilia A.

artículo científico publicado en 2009

Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis

artículo científico publicado en 2011

HELLP syndrome and its relation with the antiphospholipid syndrome

artículo científico publicado en 2013

Haemophilia A: molecular insights.

artículo científico publicado en 2007

Haemophilia B: from molecular diagnosis to gene therapy.

artículo científico publicado en 2003

Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy.

artículo científico publicado en 2009

Homocysteine and arterial thrombosis: Challenge and opportunity

artículo científico publicado en 2010

Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke.

artículo científico publicado en 2002

IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII.

artículo científico publicado en 2015

Idiopathic Budd-Chiari syndrome in a patient with homozygous Factor V Leiden and heterozygous Factor II G20210A mutations

scientific article published on 01 December 2000

Innovative use of recombinant activated factor VII during physical rehabilitation in an Italian child with Glanzmann's thromboasthenia

artículo científico publicado en 2012

Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors

artículo científico publicado en 2011

Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management

artículo científico publicado en 2002

Long-term prophylaxis with intermediate-purity factor VIII concentrate (Haemate P) in a patient with type 3 von Willebrand disease and recurrent gastrointestinal bleeding

artículo científico publicado en 2006

Magnetic resonance imaging and ultrasound evaluation of "healthy" joints in young subjects with severe haemophilia A.

artículo científico publicado en 2013

Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases

artículo científico publicado en 2014

Management of patients with factor V deficiency: open issues from the challenging history of a woman with anaphylactic transfusion reactions

artículo científico publicado en 2009

Management of patients with long-term inhibitors: is immune tolerance an underestimated life-long solution?

artículo científico publicado en 2013

Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET

artículo científico publicado en 2020

Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from Southern Italy.

artículo científico publicado en 2008

No association between the MTHFR A1298C and transcobalamin C776G genetic polymorphisms and hyperhomocysteinemia in thrombotic disease

artículo científico publicado en 2002

Non-O blood group as a risk factor for cerebral vein thrombosis

artículo científico publicado en 2013

Non-thrombotic-, non-inhibitor-associated adverse reactions to coagulation factor concentrates for treatment of patients with hemophilia and von Willebrand's disease: a systematic review of prospective studies.

artículo científico

Noninvasive assessment of liver fibrosis in patients with chronic hepatitis C (and congenital bleeding disorders): where do we stand?

artículo científico

Old and new challenges in hemophilia management

artículo científico publicado en 2013

Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence-based approaches.

artículo científico publicado en 2010

Our experience about the particular surgical management of total hip replacement in two patients with severe haemophilic arthropathy: case report

artículo científico publicado en 2013

Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians

scientific article published on 16 August 2018

Patient characteristics that influence efficacy of prophylaxis with rFVIII-FS three times per week: a subgroup analysis of the LIPLONG study

artículo científico publicado en 2014

Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey.

artículo científico publicado en 2014

Predisposing factors in patients with early-onset cerebral vein thrombosis

artículo científico publicado en 2004

Pregnancy in a woman with a history of Budd-Chiari syndrome treated by porto-systemic shunt, protein C deficiency and bicornuate uterus

artículo científico publicado en 2006

Prenatal diagnosis of haemophilia: our experience of 44 cases.

artículo científico publicado en 2013

Preventing Postsurgical Venous Thromboembolism: Pharmacological Approaches ⬇️

artículo científico publicado el 31 de marzo de 2011

Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy

artículo científico publicado en 2014

Prophylaxis in Children with Hemophilia: Evidence-Based Achievements, Old and New Challenges ⬇️

artículo científico publicado el 7 de febrero de 2012

Recombinant activated factor VII for hemostatic cover of orthopedic interventions in a girl with thrombocytopenia with absent radii syndrome

artículo científico publicado en 2007

Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype

artículo científico publicado en 2005

Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis.

scientific article published on 06 February 2013

Safety of Switching Factor VIII Products in the Era of Evolving Concentrates: Myths and Facts

artículo científico publicado en 2016

Searching for the role of primary prophylaxis in preventing inhibitor development in hemophilia A.

artículo científico publicado en 2012

Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis

artículo científico publicado en 2007

Severe bleeding in a patient with Factor XIII deficiency and COVID-19

artículo científico publicado en 2020

Successful and Safe Long-Term Standard Antiviral Therapy in a Patient with "Explosive" Immune Response in Course of HCV-Related Liver Cirrhosis

artículo científico publicado en 2015

Target of prophylaxis in severe haemophilia: more than factor levels ⬇️

artículo científico publicado el 21 de diciembre de 2012

The Infectious Burden in Atherothrombosis ⬇️

artículo científico publicado el 2 de junio de 2012

The challenge of diagnosing pulmonary embolism in children, pregnant women, and elderly patients: a descriptive review of the literature

artículo científico publicado en 2011

The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control

artículo científico publicado en 2009

Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy

artículo científico publicado en 2014

Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies.

artículo científico

Thrombotic and hemorrhagic syndromes associated with autoimmunity and infection

artículo científico publicado en 2012

Urinary excretion of iPF(2α)-III predicts the risk of future thrombotic events. A 10-year follow-up

artículo científico publicado en 2011

Lista de obras de Antonio Coppola

A role for von Willebrand factor in immune tolerance induction in patients with haemophilia A and inhibitors?

Aberrant F8 gene intron 1 inversion with concomitant duplication and deletion in a severe hemophilia A patient from Southern Italy.

Acquired haemophilia a in the elderly: case reports.

Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management

Acute coronary syndrome and severe haemophilia: an unusual association with challenging treatment

Air pollution, vascular disease and thrombosis: linking clinical data and pathogenic mechanisms.

Antiphospholipid syndrome, adrenal failure, dilated cardiomyopathy and chronic hepatitis: an unusual manifestation of multiorgan autoimmune injury?

Assessing joint involvement in haemophilia by clinical rheumatologic scores. A pilot study on similarities with subjects with psoriatic arthritis

Assessment of Hemophilic Arthropathy by Ultrasound: Where Do We Stand?

Atherothrombosis in von Willebrand Disease: An Analysis of the Literature and Implications for Clinical Management ⬇️

Bleeding and Thrombosis in Multiple Myeloma and Related Plasma Cell Disorders ⬇️

Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers

Cardiovascular risk factors and outcome in patients with retinal vein occlusion

Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis

Clinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentrates

Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients

Confronting the psychological burden of haemophilia.

Controversies in Inherited Bleeding Disorders

Coronary artery disease, cerebral non-fatal ischemic stroke in retinal vein occlusion: an 8-yr follow-up

Corrigendum

Cost of care of haemophilia with inhibitors.

Current and evolving features in the clinical management of haemophilia

Current management of the hemophilic child: a demanding interlocutor. Quality of life and adequate cost-efficacy analysis

Definition of an organisational model for the prevention and reduction of health and social impacts of inherited bleeding disorders.

Denaturing HPLC procedure for factor IX gene scanning.

Diabetes, vascular complications and antiplatelet therapy: open problems.

Effects of secondary prophylaxis started in adolescent and adult haemophiliacs

Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease.

Emerging issues on comprehensive hemophilia care: preventing, identifying, and monitoring age-related comorbidities

FEIBA versus NovoSeven in hemophilia patients with inhibitors

Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors.

Factors influencing illness representations and perceived adherence in haemophilic patients: a pilot study

First Diagnosis of Hemophilia B in a Nonagenarian.

Forum on: the role of recombinant factor VIII in children with severe haemophilia A.

Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis

HELLP syndrome and its relation with the antiphospholipid syndrome

Haemophilia A: molecular insights.

Haemophilia B: from molecular diagnosis to gene therapy.

Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy.

Homocysteine and arterial thrombosis: Challenge and opportunity

Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke.

IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII.

Idiopathic Budd-Chiari syndrome in a patient with homozygous Factor V Leiden and heterozygous Factor II G20210A mutations

Innovative use of recombinant activated factor VII during physical rehabilitation in an Italian child with Glanzmann's thromboasthenia

Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors

Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management

Long-term prophylaxis with intermediate-purity factor VIII concentrate (Haemate P) in a patient with type 3 von Willebrand disease and recurrent gastrointestinal bleeding

Magnetic resonance imaging and ultrasound evaluation of "healthy" joints in young subjects with severe haemophilia A.

Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases

Management of patients with factor V deficiency: open issues from the challenging history of a woman with anaphylactic transfusion reactions

Management of patients with long-term inhibitors: is immune tolerance an underestimated life-long solution?

Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET

Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from Southern Italy.

No association between the MTHFR A1298C and transcobalamin C776G genetic polymorphisms and hyperhomocysteinemia in thrombotic disease

Non-O blood group as a risk factor for cerebral vein thrombosis

Non-thrombotic-, non-inhibitor-associated adverse reactions to coagulation factor concentrates for treatment of patients with hemophilia and von Willebrand's disease: a systematic review of prospective studies.

Noninvasive assessment of liver fibrosis in patients with chronic hepatitis C (and congenital bleeding disorders): where do we stand?

Old and new challenges in hemophilia management

Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence-based approaches.

Our experience about the particular surgical management of total hip replacement in two patients with severe haemophilic arthropathy: case report

Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians

Patient characteristics that influence efficacy of prophylaxis with rFVIII-FS three times per week: a subgroup analysis of the LIPLONG study

Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey.

Predisposing factors in patients with early-onset cerebral vein thrombosis

Pregnancy in a woman with a history of Budd-Chiari syndrome treated by porto-systemic shunt, protein C deficiency and bicornuate uterus

Prenatal diagnosis of haemophilia: our experience of 44 cases.

Preventing Postsurgical Venous Thromboembolism: Pharmacological Approaches ⬇️

Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy

Prophylaxis in Children with Hemophilia: Evidence-Based Achievements, Old and New Challenges ⬇️

Recombinant activated factor VII for hemostatic cover of orthopedic interventions in a girl with thrombocytopenia with absent radii syndrome

Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype

Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis.

Safety of Switching Factor VIII Products in the Era of Evolving Concentrates: Myths and Facts

Searching for the role of primary prophylaxis in preventing inhibitor development in hemophilia A.

Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis

Severe bleeding in a patient with Factor XIII deficiency and COVID-19

Successful and Safe Long-Term Standard Antiviral Therapy in a Patient with "Explosive" Immune Response in Course of HCV-Related Liver Cirrhosis

Target of prophylaxis in severe haemophilia: more than factor levels ⬇️

The Infectious Burden in Atherothrombosis ⬇️